Pfizer-BioNTech Set To Supply The US Government With 105 Million COVID-19 Vaccine For US$3.2 Billion

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced on Wednesday a new vaccine supply agreement with the US government involving 105 million doses of its COVID-19 vaccine. The agreement also includes an option for Washington DC to purchase up to 195 million additional doses.

The US government will pay the biotech firms around US$3.2 billion for the initial 105 million doses, set to be delivered “as soon as late summer 2022 and continue into the fourth quarter of this year.”

“Vaccines have been and will remain critical to protecting people of all ages against COVID-19,” said Pfizer CEO Albert Bourla. “We remain proud of our long-term partnership with the U.S. government in helping to address this pandemic, and of the ongoing impact of vaccination efforts in the U.S. and around the world.”

Nord Precious Metals — sponsored Sponsored · Nord Precious Metals

The purchase, the company said, may include adult Omicron-adapted COVID-19 vaccines which are yet to secure authorization from the US Food and Drug Administration.

The announcement of the agreement comes days after the two firms announced positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-adapted COVID-19 vaccine candidates within its portfolio.

Given the agreement’s consideration, the deal puts the vaccine’s tag price at US$30.48 per dose. Should the White House exhaust the option to purchase all 300 million doses under the agreement, this puts the total agreement’s cost at US$9.14 billion–around 35.6% of Pfizer’s reported quarterly revenue in April 2022.

Pfizer’s quarterly financials
Source: Hypercharts

Pfizer last traded at US$51.78 on the NYSE while BioNTech last traded at US$142.68 on the Nasdaq.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Former Pfizer Employee Charged by SEC for Insider Trading

Former Pfizer Inc. (NYSE: PFE) employee Amit Dagar and his close friend and business partner,...

Friday, June 30, 2023, 10:58:00 AM

Crypto Market Jitters as US Government Moves $2 Billion Worth of Silk Road BTC

A wallet labeled as belonging to the US government transferred nearly 28,000 BTC to an...
Tuesday, July 30, 2024, 02:50:00 PM

Is The US Government Broke? Treasury 2025 Filing Shows $41.7T Negative Net Position

The US Treasury Department’s fiscal year 2025 consolidated financial statements show a federal government with...

Tuesday, March 24, 2026, 02:11:00 PM

BioNTech Sees Vaccine Sales Push Q1 Revenues To €6.4 Billion

While many may view the pandemic as being over, the financial results of BioNTech (NASDAQ:...

Monday, May 9, 2022, 08:02:20 AM

BioNTech Ends Q3 2021 With €6.1 Billion In Revenue

BioNTech SE (Nasdaq: BNTX) reported today its financial results for Q3 2021, highlighting quarterly revenue...

Tuesday, November 9, 2021, 09:48:00 AM